| scholarly article | Q13442814 |
| P2093 | author name string | K Kim | |
| Y K Luu | |||
| M Hadjiargyrou | |||
| B Chu | |||
| B S Hsiao | |||
| P2860 | cites work | Robust and prolonged gene expression from injectable polymeric implants | Q44148500 |
| Enzyme-carrying polymeric nanofibers prepared via electrospinning for use as unique biocatalysts | Q44167649 | ||
| Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid | Q45868044 | ||
| Electrospun nanofibrous structure: a novel scaffold for tissue engineering. | Q53693531 | ||
| Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection | Q71099227 | ||
| Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering | Q73172683 | ||
| Plasmid DNA encapsulation and release from solvent diffusion nanospheres | Q73413382 | ||
| Enhancement of transfection by physical concentration of DNA at the cell surface | Q74133485 | ||
| Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair | Q74261285 | ||
| Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles | Q77466345 | ||
| Cloning of a novel cDNA expressed during the early stages of fracture healing | Q24311358 | ||
| Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids | Q33682759 | ||
| Structure and function of lipid-DNA complexes for gene delivery | Q34001331 | ||
| Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. | Q34225065 | ||
| Growth factor release from tissue engineering scaffolds. | Q34456378 | ||
| Pluronic block copolymers: novel functional molecules for gene therapy | Q34565341 | ||
| Molecular signaling in bioengineered tissue microenvironments | Q34703945 | ||
| Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery | Q38548318 | ||
| Quantitation of supercoiled circular content in plasmid DNA solutions using a fluorescence-based method | Q39543421 | ||
| Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentiation | Q40770120 | ||
| DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers | Q40844139 | ||
| Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo | Q40891208 | ||
| DNA delivery from polymer matrices for tissue engineering | Q40945294 | ||
| In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria | Q41387920 | ||
| Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system | Q42812609 | ||
| Surface-tethered DNA complexes for enhanced gene delivery | Q42815291 | ||
| Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture | Q42825466 | ||
| Differential phosphorylation of paxillin in response to surface-bound serum proteins during early osteoblast adhesion | Q42827338 | ||
| Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. | Q43672678 | ||
| Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier | Q44015086 | ||
| A biodegradable polymer scaffold for delivery of osteotropic factors | Q44049992 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 341-353 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers | |
| P478 | volume | 89 |
| Q42914922 | A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes |
| Q59197578 | A Review: Electrospinning of Biopolymer Nanofibers and their Applications |
| Q45365056 | A new biodegradable poly-amino acid: alpha,beta-poly[(N-hydroxypropyl/aminoethyl)-DL-aspartamide-co-L-lysine], a potential nonviral vector for gene delivery |
| Q35884678 | A short review: Recent advances in electrospinning for bone tissue regeneration |
| Q37809149 | Active Wound Coverings: Bioengineered Skin and Dermal Substitutes |
| Q38087300 | Addition of nanoscaled bioinspired surface features: A revolution for bone related implants and scaffolds? |
| Q37103471 | Advances in drug delivery via electrospun and electrosprayed nanomaterials |
| Q37202807 | Advancing tissue engineering by using electrospun nanofibers |
| Q36749722 | Aligned Protein-Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue-Engineering Platform |
| Q33729392 | An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. |
| Q39301728 | Application of electrospun fibers for female reproductive health |
| Q37810815 | Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications |
| Q40757427 | Biodegradable fibre scaffolds incorporating water-soluble drugs and proteins |
| Q57920810 | Biodegradable polymers-an overview |
| Q36173769 | Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications. |
| Q61813786 | Biomedical Applications of Electrospun Nanofibers: Drug and Nanoparticle Delivery |
| Q37059905 | Biomimetic and bioactive nanofibrous scaffolds from electrospun composite nanofibers. |
| Q36502929 | Biomimetic materials for tissue engineering |
| Q49834140 | Biphasic drug release from electrospun polyblend nanofibers for optimized local cancer treatment |
| Q53464416 | Bone morphogenetic protein-2-encapsulated grafted-poly-lactic acid-polycaprolactone nanoparticles promote bone repair. |
| Q34533701 | Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells |
| Q39017300 | Cell and biomolecule delivery for regenerative medicine |
| Q57813435 | Characterization of PLGA/Chitosan Electrospun Nano-Biocomposite Fabricated by Two Different Methods |
| Q33719254 | Characterizing DNA condensation and conformational changes in organic solvents |
| Q40198603 | Coating of electrospun poly(lactic-co-glycolic acid) nanofibers with willemite bioceramic: improvement of bone reconstruction in rat model. |
| Q39660776 | Coating of hydrophobins on three-dimensional electrospun poly(lactic-co-glycolic acid) scaffolds for cell adhesion |
| Q45866211 | Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering. |
| Q64063046 | Comparative Study of Mushroom Grown on Modified PAN Nanofiber Mats |
| Q42835016 | Control of degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) nanofiber scaffolds for biomedical applications. |
| Q40471957 | Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method. |
| Q50533696 | Co‐electrospun fibrous scaffold–adsorbed DNA for substrate‐mediated gene delivery |
| Q39108253 | Current manufacturing processes of drug-eluting sutures |
| Q35539524 | DOX-Cu9S5@mSiO2-PG composite fibers for orthotopic synergistic chemo- and photothermal tumor therapy |
| Q57376901 | Dendrimer-functionalized electrospun cellulose acetate nanofibers for targeted cancer cell capture applications |
| Q36728876 | Design and preparation of polymeric scaffolds for tissue engineering |
| Q59197564 | Designing electrospun nanofiber mats to promote wound healing – a review |
| Q47655569 | Development of arginine-glycine-aspartate-immobilized 3D printed poly(propylene fumarate) scaffolds for cartilage tissue engineering |
| Q37799099 | Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation |
| Q37990460 | Development of tissue engineered vascular grafts and application of nanomedicine |
| Q37807529 | Differentiation of stem cells: strategies for modifying surface biomaterials |
| Q36092534 | Directed Assembly of Soft Anisotropic Nanoparticles by Colloid Electrospinning |
| Q54627044 | Drug loading and delivery using nanofibers scaffolds. |
| Q37451635 | Drug releasing systems in cardiovascular tissue engineering |
| Q50934242 | Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. |
| Q57341691 | Effect of experimental parameters on the formation of chitosan-poly(acrylic acid) nanofibrous scaffolds and evaluation of their potential application as DNA carrier |
| Q48544863 | Effect of polyvinylidene fluoride electrospun fiber orientation on neural stem cell differentiation. |
| Q59158179 | Efficiency of Microfiltration Systems for the Removal of Bacterial and Viral Contaminants from Surface and Rainwater |
| Q92341122 | Efficient nanocarriers of siRNA therapeutics for cancer treatment |
| Q37570722 | Electrohydrodynamics: A facile technique to fabricate drug delivery systems |
| Q64990260 | Electrospinning Nanofibers for Therapeutics Delivery. |
| Q44979718 | Electrospinning of chitosan solutions in acetic acid with poly(ethylene oxide). |
| Q38383252 | Electrospinning strategies of drug-incorporated nanofibrous mats for wound recovery |
| Q57171681 | Electrospinning: processing technique for tissue engineering scaffolding |
| Q38269433 | Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals |
| Q49575962 | Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications |
| Q38664015 | Electrospun Fibers for Spinal Cord Injury Research and Regeneration |
| Q36825900 | Electrospun Microfiber Scaffolds with Anti-Inflammatory Tributanoylated N-Acetyl-d-Glucosamine Promote Cartilage Regeneration |
| Q90221482 | Electrospun Nanofibers as Carriers of Microorganisms, Stem Cells, Proteins, and Nucleic Acids in Therapeutic and Other Applications |
| Q93060831 | Electrospun Poly(lactide-co-glycolide-co-3(S)-methyl-morpholine-2,5-dione) Nanofibrous Scaffolds for Tissue Engineering |
| Q57342135 | Electrospun fibrous membranes for efficient heavy metal removal |
| Q33250171 | Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro |
| Q35552680 | Electrospun nanofibers as versatile interfaces for efficient gene delivery |
| Q34660947 | Electrospun nanofibers for regenerative medicine |
| Q37038858 | Electrospun nanostructured scaffolds for tissue engineering applications |
| Q34366361 | Electrospun scaffolds for tissue engineering of vascular grafts |
| Q37400058 | Electrostatic micro- and nanoencapsulation and electroemulsification: a brief review |
| Q57828698 | Emulsion-based systems for fabrication of electrospun nanofibers: food, pharmaceutical and biomedical applications |
| Q50947617 | Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes. |
| Q37036569 | Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice |
| Q39369257 | Fabrication and evaluation of electrospun collagen/poly(N-isopropyl acrylamide)/chitosan mat as blood-contacting biomaterials for drug delivery |
| Q53618454 | Fabrication of electrospun zein nanofibers for the sustained delivery of siRNA. |
| Q38703535 | Facile electrospinning of an efficient drug delivery system |
| Q35207503 | Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors |
| Q36947542 | Functional electrospun nanofibrous scaffolds for biomedical applications |
| Q37347132 | Functionalizing electrospun fibers with biologically relevant macromolecules |
| Q36314939 | Gene delivery from polymer scaffolds for tissue engineering |
| Q36748645 | Gene therapy used for tissue engineering applications. |
| Q57340501 | Hybrid Metal Nanoparticle-Containing Polymer Nanofibers for Environmental Applications |
| Q34701296 | Hydrogel-electrospun fiber mat composite coatings for neural prostheses. |
| Q50522949 | Hydrophilized 3D porous scaffold for effective plasmid DNA delivery. |
| Q94686446 | In situ 3D-patterning of electrospun fibers using two-layer composite materials |
| Q24813608 | In vitro non-viral gene delivery with nanofibrous scaffolds |
| Q57284532 | Inhibition of radical-induced oxidative DNA damage by antioxidants loaded in electrospun polylactide nanofibers |
| Q40166555 | Investigation of fibroblast and keratinocyte cell-scaffold interactions using a novel 3D cell culture system. |
| Q44963619 | Lamellar stack formation and degradative behaviors of hydrolytically degraded poly(ε-caprolactone) and poly(glycolide-ε-caprolactone) blended fibers |
| Q55413040 | Lycium barbarum polysaccharide encapsulated Poly lactic-co-glycolic acid Nanofibers: cost effective herbal medicine for potential application in peripheral nerve tissue engineering. |
| Q98290916 | Maneuvering the Migration and Differentiation of Stem Cells with Electrospun Nanofibers |
| Q36826532 | Matrices and scaffolds for DNA delivery in tissue engineering |
| Q37004190 | Mechanical properties of single electrospun drug-encapsulated nanofibres |
| Q43354705 | Mechanically enhanced PES electrospun nanofiber membranes (ENMs) for microfiltration: The effects of ENM properties on membrane performance |
| Q45754039 | Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization |
| Q33936371 | Multi-porous electroactive poly(L-lactic acid)/polypyrrole composite micro/nano fibrous scaffolds promote neurite outgrowth in PC12 cells |
| Q57353088 | Multifunctional electrospinning composite fibers for orthotopic cancer treatment in vivo |
| Q42170358 | Nano-fibrous tissue engineering scaffolds capable of growth factor delivery |
| Q38200078 | Nano/microfibrous polymeric constructs loaded with bioactive agents and designed for tissue engineering applications: a review |
| Q39066848 | Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy |
| Q38218199 | Nanofiber: Synthesis and biomedical applications. |
| Q37783536 | Nanofibers Offer Alternative Ways to the Treatment of Skin Infections |
| Q34667748 | Nanofibers and their applications in tissue engineering |
| Q38542278 | Nanofibers used for delivery of antimicrobial agents |
| Q59197557 | Nanofibers: Electrospinning of Biopolymers |
| Q27022421 | Nanofibrous scaffolds in biomedical applications |
| Q38201642 | Nanoparticles meet electrospinning: recent advances and future prospects. |
| Q43106332 | Nanostructured Biomaterials for Regeneration |
| Q34020764 | Nanostructured polymer scaffolds for tissue engineering and regenerative medicine |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q33688700 | New directions in nanofibrous scaffolds for soft tissue engineering and regeneration |
| Q46134024 | Nitroxyl radical incorporated electrospun biodegradable poly(ester Amide) nanofiber membranes |
| Q38766332 | Nonwoven Polymer Nanofiber Coatings That Inhibit Quorum Sensing in Staphylococcus aureus: Toward New Nonbactericidal Approaches to Infection Control. |
| Q49092553 | Novel Poly(Diol Sebacate)s as Additives to Modify Paclitaxel Release From Poly(Lactic-co-Glycolic Acid) Thin Films. |
| Q58097137 | Novel routes to epoxy functionalization of PHA-based electrospun scaffolds as ways to improve cell adhesion |
| Q55370590 | Optimization of Poly(methyl vinyl ether-co-maleic acid) Electrospun Nanofibers as a Fast-Dissolving Drug Delivery System. |
| Q47648047 | Oriented Nanofibrous Polymer Scaffolds Containing Protein-Loaded Porous Silicon Generated by Spray Nebulization. |
| Q44992348 | Peripheral nerve regeneration using composite poly(lactic acid‐caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning |
| Q40175470 | Poly(L-lactic acid)/hydroxyapatite hybrid nanofibrous scaffolds prepared by electrospinning |
| Q33694279 | Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. |
| Q39096569 | Polyelectrolyte multilayer coating of 3D scaffolds enhances tissue growth and gene delivery: non-invasive and label-free assessment |
| Q41276236 | Polymer nanofibrous structures: Fabrication, biofunctionalization, and cell interactions |
| Q35230879 | Polymeric nanofibers in tissue engineering |
| Q37395881 | Problem of hydroxyapatite dispersion in polymer matrices: a review |
| Q38261056 | Progress of electrospun fibers as nerve conduits for neural tissue repair |
| Q37468810 | Putting Electrospun Nanofibers to Work for Biomedical Research |
| Q36259105 | Recent development of polymer nanofibers for biomedical and biotechnological applications |
| Q33733193 | Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. |
| Q64986940 | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications. |
| Q64923746 | Release Profile of Gentamicin Sulfate from Polylactide-co-Polycaprolactone Electrospun Nanofiber Matrices. |
| Q35079185 | Release of bacteriocins from nanofibers prepared with combinations of poly(d,l-lactide) (PDLLA) and poly(ethylene oxide) (PEO). |
| Q50955908 | S/O-nanodispersion electrospun fiber mesh effective for sustained release of healthy plasmid DNA with the structural and functional integrity. |
| Q57284560 | Scaffolds constituted by mixed polylactide and poly(ethylene glycol) electrospun microfibers |
| Q55918668 | Scaffolds for tissue fabrication |
| Q57284565 | Scaffolds with tuneable hydrophilicity from electrospun microfibers of polylactide and poly(ethylene glycol) mixtures: morphology, drug release behavior, and biocompatibility |
| Q35836180 | Small molecule delivery through nanofibrous scaffolds for musculoskeletal regenerative engineering |
| Q38537491 | Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review |
| Q53644043 | Structure and properties of porous films based on aliphatic copolyamide developed for cellular technologies. |
| Q41874530 | Surface Functional Poly(lactic Acid) Electrospun Nanofibers for Biosensor Applications. |
| Q38507265 | Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications |
| Q59615542 | Surface modified cellulose scaffolds for tissue engineering |
| Q38791884 | Targeted brain delivery nanoparticles for malignant gliomas. |
| Q30458939 | Techniques for fabrication and construction of three-dimensional scaffolds for tissue engineering |
| Q48617827 | The effects of nanofiber topography on astrocyte behavior and gene silencing efficiency. |
| Q36675915 | The role of electrospinning in the emerging field of nanomedicine. |
| Q38208616 | Therapeutic application of electrospun nanofibrous meshes |
| Q38106755 | Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size |
| Q37669198 | Tissue Engineering with Nano-Fibrous Scaffolds |
| Q36717650 | Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration |
| Q40051352 | Tissue engineering of urethra using human vascular endothelial growth factor gene-modified bladder urothelial cells |
| Q33757392 | Tissue extracellular matrix nanoparticle presentation in electrospun nanofibers |
| Q53458423 | Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization. |
| Q34680783 | Water-soluble electrospun nanofibers as a method for on-chip reagent storage |
Search more.